Background
Health-related stigma
Conceptual model
Stigma measurement
Instruments to measure public stigma
Social Distance Scale (SDS)
EMIC Community Stigma Scale (EMIC-CSS)
Instruments to measure stigma experienced by those with the condition
Berger Stigma Scale
EMIC affected persons
Internalized Stigma of Mental Illness (ISMI) scale
Stigma interventions
Cross-condition methods to address public stigma
Information-based interventions
Contact between persons with the condition and the community, health professionals, or others
Change agents/Popular opinion leaders (POLs)
Cross-condition methods to address stigma experienced by persons affected
(Peer) counselling
Skills building and empowerment
Evidence of how measurement instruments are used across conditions
Author | Country | Condition | Target group |
N
| Evidence of validity | Comments |
---|---|---|---|---|---|---|
SDS | ||||||
Link et al. [90] | USA | Mental health conditions | Random sample of Ohio residents | 151 | Alpha 0.92 | |
Lee et al. [91] | USA | HIV and AIDS | College students | 818 | No validation was reported | The SDS in this study used different items from the one adapted by Link et al. [90] used in all other studies |
Indonesia | Leprosy | Community in an endemic district | 259, 213 and 375 | Alpha 0.87, SDCa 0.60, ICC 0.75 (95% CI 0.62–0.84); no floor or ceiling effects | ||
Sikorski et al. [92] | Germany | Obesity | Telephone sample of general public | 1008 | Alpha 0.86 | |
Pachankis et al. [120] | USA | 44 health conditions | Experts and general public | 1025 | Alpha 0.84 (expert raters); 0.83 general public raters | |
EMIC | ||||||
Vlassoff et al. [93] | Nigeria Cameroon, Ghana, Uganda | Onchocerciasis | Unaffected persons | 410 | Alpha 0.76 | 12-item EMIC was used |
Chowdhury et al. [49] | India | Mental health conditions | Non-affected lay persons | 21 | Kappa 0.90 (inter-rater) | 20–25 items, depending on version |
Stienstra et al. [94] | Ghana | Buruli ulcer | Healthy controls | 33 | Alpha 0.76 | 15-item EMIC |
Rensen et al. [96] | India | Leprosy | Non-affected community | 806 | Alpha 0.83; no floor or ceiling effects | 13-item EMIC |
Indonesia | Leprosy | Community in an endemic district | 259, 213 and 375 | Alpha 0.83, SDCa 0.81, ICC 0.84 (95% CI 0.75–0.90); no floor or ceiling effects | 15-item EMIC | |
Kaehler et al. [97] | Thailand | Leprosy | Community in an endemic district | 257 | No validation was reported | 15-item EMIC |
Adhikari et al. [133] | Nepal | Leprosy | Community in an endemic district | 281 | No validation was reported | 15-item EMIC |
Sermrittirong et al. [95] | Thailand | Leprosy, tuberculosis | Community in an endemic district | 236 | No validation was reported | 15-item EMIC |
Author | Country | Condition | Target group |
N
| Evidence of validity | Comments |
---|---|---|---|---|---|---|
Berger stigma scale | ||||||
Berger et al. [24] | USA | HIV | People with HIV | 318 | Alpha 0.96; alpha sub-scales 0.90–0.93, correlation coefficient reliability 0.92. Construct validity supported by correlation with Rosenberg Self-esteem scale and Center for Epidemiological Studies-Depression scale | |
Dadun et al. [98] | Indonesia | Leprosy | Persons affected by leprosy | 392 | Alpha 0.88; sub-scale alphas 0.79–0.84, SDCa 1.37, ICC 0.75 (95% CI 0.64–0.83); no floor or ceiling effects; construct validity supported by correlation with the P-scale and WHOQOL-BREF | Renamed ‘SARI Stigma Scale’ because of substantial changes to structure |
Rump et al. [53] | Netherlands | MRSA | MRSA carriers | 57 | Validity was supported by correlation with the RAND mental health inquiry | An adapted version was used |
ISMI | ||||||
Boyd Ritsher et al. [44] | USA | Mental health conditions | Mental health outpatients | 127 | Alpha 0.90 (sub-scales 0.58–0.80); test-retest reliability r = 0.92 (n = 16) (sub-scales 0.68–0.94); good construct validity | 29 items |
Brohan et al. [134] | 13 European countries | Bipolar disorder and depression | Mental health patients | 1182 | Alpha 0.94; construct validity supported by strong correlations with an empowerment scale and a devaluation and discrimination scale | 24-item ISMI was used, excluding the Resilience sub-scale |
Singh et al. [135] | India | Mental health | Persons with severe mental disorders | 161 | Alpha 0.86; ICC test-retest reliability (n = 31) sub-scales range 0.84–0.96; 5-component structure supported by factor analysis; good correlation with EMIC | |
Luoma et al. [99] | USA | Substance abuse | Adults with a substance use disorder | 88 | Alpha 0.82 and 0.92 at pre- and post-assessment | |
Stevelink et al. [101] | India | HIV Leprosy | Patients/persons affected | 95 HIV 95 leprosy | Alpha 0.87 Alpha 0.91 | |
Rensen et al. [96] | India | Leprosy | Affected persons | 806 | Alpha 0.96; sub-scale alphas 0.79–0.96; weighted kappa 0.62 (n = 49); no floor or ceiling effects | 18-item ISMI |
Taft et al. [100] | USA | Inflammatory bowel disease | Irritable bowel disease patients | 191 | No validation was reported | |
Arachchi et al. [136] | Sri Lanka | Leprosy | Affected persons | 132 | No validation was reported | |
EMIC affected persons | ||||||
Weiss et al. [45] | India | Leprosy, mental health | Patients | 56 + 31 controls | Item-wise kappa values 0.62–0.93 (n = 16–18); association with established mental health instruments (SCID and HDARS)bsupported construct validity | 8-item EMIC |
India | Depression, schizophrenia | Patients Family, caretakers | 80 80 | Alpha 0.71 Alpha 0.81 | 10-item EMIC 13-item EMIC | |
Brieger et al. [105] | Nigeria | Onchocerciasis | Patients | 500 | No validation was reported | 13-item EMIC was used |
Vlassoff et al. [93] | Nigeria Cameroon Ghana Uganda | Onchocerciasis | Patients | 469 | Alpha 0.80 | 13-item EMIC was used |
Chowdhury et al. [49] | India | Mental health conditions | Patients | 25 | Kappa 0.89 (inter-rater) | 20-25 items, depending on version |
Stienstra et al. [94] | Ghana | Buruli ulcer | Patients | 33 | Alpha 0.65 (of 11 items asked of both patients and controls) | 15-item EMIC |
Weiss et al. [106] | Bangladesh India Malawi Colombia | Tuberculosis | Patients | 102 127 100 98 | Alpha 0.77 Alpha 0.85 Alpha 0.63 Alpha 0.65 | 18-item EMIC |
Stevelink et al. [101] | India | HIV Leprosy | Patients/persons affected | 95 HIV 95 leprosy | Alpha 0.76 Alpha 0.83 | |
Rensen et al. [96] | India | Leprosy | Patients | 806 | Alpha 0.88; weighted kappa 0.70; no floor or ceiling effects | 17-item EMIC |
Grover et al. [104] | India | Bi-polar disorder | Patients | 185 | Alpha 0.94; good correlation with ISMI and Participation scale scores | 15-item EMIC |
Arachchi et al. [136] | Sri Lanka | Leprosy | Patients | 132 | No validation was reported | Not reported |
Evidence of how stigma interventions are used across conditions
Author | Country | Condition | Target group |
N
| Evidence of effectiveness | Comments |
---|---|---|---|---|---|---|
Information-based approaches | ||||||
Masuda et al. [107] | USA | Psychological disorders | College students | 95 (43 + 52) | The CAMI scores for the educational workshop lowered at post-intervention and 1-month follow-up among participants with higher levels of psychological flexibility (scored 67 or higher on the Acceptance and Action Questionnaire) | CAMI administered at beginning and end of workshop, and at 1-month follow-up |
Boulay et al. [108] | Ghana | HIV | General public | 2746, 2926 | Attitudes related to a punitive response to PLHA both improved over time and were positively associated with exposure to the program’s campaign; overall, respondents exposed to the campaign were 45% more likely than those not exposed to be willing to care for a HIV-infected relative, and 43% more likely to believe that an HIV-infected female teacher should be allowed to continue teaching | |
Peters et al. [109] | Indonesia | Leprosy | Community in an endemic district | 213 and 375 | Knowledge about leprosy increased and that negative attitudes reduced significantly; at baseline, 87% considered leprosy curable and 31% thought leprosy was still contagious after treatment; this had improved after the contact event to 98% and 7%, respectively | Post-intervention result measured after 3 months |
Contact | ||||||
Peters et al. [109] | Indonesia | Leprosy | Community in an endemic district | 213 and 375 | The EMIC and SDS stigma scores reduced both among those attending ‘contact events’ (effect sizes 0.75 and 0.81, respectively) and in the wider community (effect size 0.47 and 0.54) | Contact was through testimonies on video plus a live testimony given at ‘contact events’ with community groups; post-intervention results were measured on average 1–1.5 years after the contact events |
Corrigan et al. [110] | USA | Mental illness | College students | 257 | Participants in the contact intervention group showed significant reduction in avoidance and segregation factors with the Attribution Questionnaire at post-intervention and 1-week follow-up; participants in contact condition also showed significant reduction in pity and improvement in power from pre- to post-intervention | Contact through video was used; measures administered pre-test, post-test, 1-week follow-up |
Paxton [137] | ? | HIV | Young people | 1230 | HIV-positive speakers were effective in decreasing fear and stigmatization among the audience; meeting HIV-positive people decreased fear and prejudice, reinforced messages about protective behavior and increased the belief that HIV is preventable; the improved attitudes remained significant over 3 months | |
Uys et al. [71] | Lesotho, Malawi, South Africa, Swaziland, Tanzania | HIV | Nurses PLHA | 41 PLHA 134 nurses | PLHA involved in the intervention teams reported less stigma and increased self-esteem; nurses in the intervention teams and those in the target group reported no reduction in stigma or increases in self-esteem and self-efficacy, but their HIV testing behavior increased significantly | A pre- and post-test was done to measure stigma, self-esteem and self-efficacy; the post-test was conducted within 1 month after the intervention |
Yiu et al. [111] | Hong Kong | HIV | Nursing students | 89 | In both the knowledge-only group and the knowledge-contact group, significant improvement in AIDS knowledge, stigmatizing attitudes, fear of contagion, willingness to treat, and negative affect were found at post-test; the effects on AIDS knowledge, fear of contagion, willingness to treat, and negative affect were sustained at follow-up for both groups Intergroup comparisons at post-test showed that the effectiveness of the knowledge-contact program was significantly greater than the knowledge program in improving stigmatizing attitudes; no significant difference between the two groups was found at follow-up | |
Change agents/ Popular opinion leaders | ||||||
Kelly et al. [114] | USA | HIV | Gay men | 8 cities | In the four intervention cities a statistically significant reduction was found in the mean frequency of unprotected anal intercourse during the previous 2 months and a significant increase in the mean percentage of occasions of anal intercourse protected by condoms | |
Cross & Choudhury [76] | Nepal | Leprosy | Community | 152 SHG participants | The Stigma Elimination Programme had a significant impact at community level and is recognized as a positive force by district level officials of Her Majesty’s Government of Nepal; as direct effects of SHG activity, 1060 people have had some basic education, many people now have access to clean water, some have the benefits of improved sanitation and others have improved physical access to amenities, over 200 people are now generating income from their own micro enterprises | |
Young et al. [77] | Peru | HIV | Community | 1327 POL, 1722 comparison | HIV-related stigma significantly reduced from baseline to 12-month follow-up and from baseline to 24-month follow-up among participants in the POL intervention | 5 stigma items assessed at baseline, 12-month, and 24-month follow-up |
Li et al. [78] | China | HIV | Healthcare workers | 1750 POL | Reduced prejudicial attitudes (estimated difference = – 2.40; p < 0.001), reduced avoidance intent towards people living with HIV (estimated difference = – 1.10; p < 0.001), and increased institutional support in the hospitals (estimated difference = 0.39; p = 0.003) at 6 months after controlling for service providers’ background factors and clinic-level characteristics | The intervention effects (6 months) were sustained and strengthened at 12 months |
The concept of health-related stigma
Towards common stigma measurement approaches for health-related stigma
Towards common stigma intervention approaches for health-related stigma
Author | Country | Condition | Target group |
N
| Evidence of effectiveness | Comments |
---|---|---|---|---|---|---|
(Peer) counselling/education | ||||||
Nuwaha et al. [115] | Uganda | HIV | Adults in the community | 1402 before; 1562 after | The proportion of people who had ever tested for HIV increased from 18.6% to 62% (p < 0.001). Among people who had ever tested, the proportion who disclosed their HIV test result to a sexual partner increased from 41% to 57% (p < 0.001). The proportion who wanted the infection status of a family member not to be revealed decreased from 68% to 57% (p < 0.001) | This concerned a home-based counselling and testing program |
Jürgensen et al. [116] | Zambia | HIV | Adult 16 and above | 1500 pre 1107 post | There was an overall reduction of 7% in stigma from baseline to follow-up, mainly due to a reduction in individual stigmatizing attitudes but not in perceived stigma; the reduction did not differ between the trial arms (p = 0.423) Being tested for HIV was associated with a reduction in stigma (p = 0.030) and HBVCT had a larger impact on stigma than other testing approaches (p = 0.080 vs. p = 0.551) | HBVCT trial |
Conner et al. [117] | USA | Mental illness | Older adults with depression in community | 19 | ISMI scores significantly reduced after participating in the 3-month peer educator intervention | |
Lusli et al. [82] | Indonesia | Leprosy | Persons affected by leprosy | 67 clients; 57 controls | Significant reduction was observed between the before and after total SARI Stigma scale scores (mean difference clients 9.6 vs. 5.6 for controls), Participation scale scores (mean difference clients 3.7 vs. 1.4 for controls) and WHOQOL-BREF scores (mean difference clients +6.5 vs. – 2.0 for controls) | Outcome assessed on average 1–1.5 years after baseline |
Skills building and empowerment | ||||||
Cross & Choudhary [76] | Nepal | Leprosy | Persons affected by leprosy | 152 SHG participants and 102 controls | Social participation in the intervention group (where participants were working as change agents) was much better than in the control group; the median scores on the Participation scale were 0 and 7, respectively (p < 0.0001, Kruskal–Wallis test) | |
Bellamy & Mowbray [119] | USA | Mental health conditions | Adults with mental illness | 397 | After a 6-month follow-up, those with greater participation showed greater quality of life, empowerment, school/vocational enrollment, and encouragement from mental health workers; a significant condition effect was found for empowerment (p < 0.01) and for school efficacy (p < 0.05); at 12-month follow-up, college or vocational enrollment had increased significantly | |
Dalal [72] | India | Disabilities | Persons with disabilities | The project resulted in four types of outcomes: (1) increased visibility and participation of people with disabilities in community activities; many of them stepped out of their houses for the first time; (2) the number of physically challenged attending meetings gradually increased from none to 30–40% during the 3 years; (3) there was almost a 150% increase in immunization against polio in the third year; (4) a greater number of people were reaching out to hospitals and rehabilitation centers in a nearby city; people who earlier thought that nothing could be done were now exploring the possibilities of medical rehabilitation with community support | ||
Uys et al. [71] | Lesotho, Malawi, South Africa, Swaziland, Tanzania | HIV | Nurses PLHA | 41 PLHA 134 nurses | PLHA involved in the intervention teams reported less stigma and increased self-esteem Nurses in the intervention teams and those in the target group reported no reduction in stigma or increases in self-esteem and self-efficacy, but their HIV testing behavior increased significantly | Pre- and post-test measured stigma, self-esteem and self-efficacy; the post-test was conducted within 1 month after the intervention |
Dadun et al. [85] Dadun et al. (submitted) | Indonesia | Leprosy | Persons affected by leprosy | 20 qualitative + 30 quantitative | In qualitative interviews, clients reported growing businesses, better self-esteem, improved interaction with neighbor and most also less stigma than before; in some cases, disclosure concern remained high; in the quantitative interviews, the mean difference between the pre- and post-assessment total score of the SARI Stigma scale for socioeconomic development clients and the control group was 10.0 vs. 6.7, for the Participation scale 3.6 vs. 1.4 and for the WHOQOL-BREF + 4.32 vs. – 2.00 | Outcome assessed on average 1–1.5 years after baseline |
Limitations
Conclusions
-
Researchers, research funders, public health and social services managers, and health and social services practitioners should adopt cross-cutting, more cost-effective approaches to health-related stigma, seeking to use generic instruments and interventions where possible.
-
Stigma studies should demonstrate how stigma theory and frameworks apply across conditions and delineate commonalities, as well as condition-specific exceptions that might be important for understanding, measurement, or interventions.
-
Researchers studying stigma should approach the issues more generically, adapting (potentially) generic stigma instruments to containing an optimal common core of items, identifying, where necessary, condition-specific add-on items or modules.
-
Stigma studies should be commissioned to demonstrate the advantages and effectiveness of cross-condition approaches to measurement and interventions.